Factors Affecting the Price of BRAFTOVI

BRAFTOVI (encorafenib), a kinase inhibitor for specific cancers, has a price influenced by multiple factors.

Factors Affecting the Price of BRAFTOVI

Firstly, R&D costs are high. Developing this drug for BRAF V600 - mutated cancers involved substantial investment in research and clinical trials.

Moreover, production costs matter. Precise manufacturing processes and strict quality control add to expenses. Market demand also impacts the price. If the demand for treating melanoma or colorectal cancer with this drug is high, prices may be maintained at a certain level.

Encorafenib(BRAFTOVI)

For the treatment of melanoma, colorectal cancer (CRC), and non-small cell lung cancer (NSCLC).

CATEGORY NAVIGATION

What are the side effects of Encorafenib?

Encorafenib IS AN ORAL SMALL MOLECULE BRAF INHIBITOR DEVELOPED BY ARRAY BIOPHARMA IN THE UNITED STATES. In the...

Wednesday, June 18th, 2025, 16:14

Adverse effects of Encorafenib(BRAFTOVI)

Encorafenib (BRAFTOVI) is a therapeutic drug that targets BRAF gene mutations, which may cause a series of adverse...

Wednesday, June 18th, 2025, 16:09

What are the side effects of Encorafenib?

Encorafenib in combination with bimetinib is indicated for the treatment of adult patients with metastatic NSCLC...

Wednesday, June 18th, 2025, 16:04

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

Mailbox:Info@Lucius.La

Welcome To Consult